Patents by Inventor Henrik Oestergaard

Henrik Oestergaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COAGULATION FACTOR VII POLYPEPTIDES
    Publication number: 20180142227
    Abstract: The present invention relates to modified coagulation Factor VII polypeptides exhibiting increased resistance to antithrombin inactivation and enhanced proteolytic activity. The present invention also relates to polynucleotide constructs encoding such polypeptides, vectors and host cells comprising and expressing such polynucleotides, pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: January 17, 2018
    Publication date: May 24, 2018
    Applicant: Novo Nordisk HealthCare AG
    Inventors: Henrik Oestergaard, Prafull S. Gandhi, Ole Hvilsted Olsen
  • Polypeptides having peroxygenase activity
    Patent number: 9920341
    Abstract: The present invention relates to isolated polypeptides having peroxygenase activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: March 20, 2018
    Assignee: Novozymes A/S
    Inventors: Sara Landvik, Lars Henrik Oestergaard, Lisbeth Kalum
  • Polypeptides Having N-Acetyl Glucosamine Oxidase Activity
    Publication number: 20180000076
    Abstract: The present invention relates to polypeptides having N-acetyl glucosamine oxidase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: December 16, 2015
    Publication date: January 4, 2018
    Applicant: Novozymes A/S
    Inventors: Kirk Matthew Schnorr, Marianne Thorup Cohn, Lars Henrik Oestergaard
  • FACTOR VII CONJUGATES
    Publication number: 20170355974
    Abstract: The present invention relates to the conjugation of Factor VII polypeptides with heparosan polymers. The resultant conjugates may be used to deliver Factor VII, for example in the treatment or prevention of bleeding disorders.
    Type: Application
    Filed: March 8, 2017
    Publication date: December 14, 2017
    Inventors: Carsten Behrens, Henrik Oestergaard, Henning Ralf Stennicke
  • Lipase Variants and Polynucleotides Encoding Same
    Publication number: 20170314001
    Abstract: The present invention relates to a variant of a parent lipase, wherein said variant has at least 60% but less than 100% sequence identity with SEQ ID NO: 2, has lipase activity, comprises a substitution at a position corresponding to position 92 and/or 96; and remains unaltered at the positions corresponding to positions 231, 233 and 254 of SEQ ID NO:2. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: December 1, 2015
    Publication date: November 2, 2017
    Applicant: Novozymes A/S
    Inventors: Allan Svendsen, Jesper Vind, Lone Baunsgaard, Jakob Skjold-Joergensen, Vikram Kjoeller Bhatia, Lars Henrik Oestergaard
  • Polypeptides having peroxygenase activity
    Patent number: 9719072
    Abstract: The present invention relates to isolated polypeptides having peroxygenase activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. A polynucleotide encoding a peroxygenase was isolated from Thielavia hyrcaniae.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: August 1, 2017
    Assignee: Novozymes A/S
    Inventors: Sara Landvik, Lars Henrik Oestergaard, Lisbeth Kalum
  • Human Coagulation Factor VII Polypeptides
    Publication number: 20170198274
    Abstract: The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as polynucleotide constructs encoding such variants, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: February 24, 2017
    Publication date: July 13, 2017
    Inventors: Henrik Oestergaard, Ole Hvilsted Olsen, Katrine Skaarup Larsen, Henning Stennicke
  • POLYPEPTIDES HAVING PEROXYGENASE ACTIVITY
    Publication number: 20170183697
    Abstract: The present invention relates to isolated polypeptides having peroxygenase activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: March 9, 2017
    Publication date: June 29, 2017
    Applicant: Novozymes A/S
    Inventors: Sara Landvik, Lars Henrik Oestergaard, Lisbeth Kalum
  • Color modification of textile
    Patent number: 9670614
    Abstract: The use of a peroxidase, a source of hydrogen peroxide and a mediator for providing a modified color in the textile is described.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: June 6, 2017
    Assignee: Novozymes A/S
    Inventors: Yucheng Zhou, Chu Wang, Lisbeth Kalum, Lars Henrik Oestergaard, Wenqi Huang
  • Polypeptides having peroxygenase activity
    Patent number: 9670468
    Abstract: The present invention relates to isolated polypeptides having peroxygenase activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: June 6, 2017
    Assignee: Novozymes A/S
    Inventors: Sara Landvik, Lars Henrik Oestergaard, Lisbeth Kalum
  • COAGULATION FACTOR VII POLYPEPTIDES
    Publication number: 20170096655
    Abstract: The present invention relates to modified coagulation Factor VII polypeptides exhibiting increased resistance to antithrombin inactivation and enhanced proteolytic activity. The present invention also relates to polynucleotide constructs encoding such polypeptides, vectors and host cells comprising and expressing such polynucleotides, pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: May 18, 2016
    Publication date: April 6, 2017
    Inventors: Henrik Oestergaard, Prafull S. Gandhi, Ole Hvilsted Olsen
  • Polypeptides having peroxygenase activity
    Patent number: 9611459
    Abstract: The present invention relates to isolated polypeptides having peroxygenase activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. A polynucleotide encoding a peroxygenase was isolated from Myceliophthora fergusii.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: April 4, 2017
    Assignee: Novozymes A/S
    Inventors: Sara Landvik, Lars Henrik Oestergaard, Lisbeth Kalum
  • Polypeptides Having Peroxygenase Activity
    Publication number: 20170081645
    Abstract: The present invention relates to isolated polypeptides having peroxygenase activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: December 6, 2016
    Publication date: March 23, 2017
    Applicant: Novozymes A/S
    Inventors: Sara Landvik, Lars Henrik Oestergaard, Lisbeth Kalum
  • Polypeptides Having Peroxygenase Activity
    Publication number: 20170081644
    Abstract: The present invention relates to isolated polypeptides having peroxygenase activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: December 5, 2016
    Publication date: March 23, 2017
    Applicant: Novozymes A/S
    Inventors: Sara Landvik, Lars Henrik Oestergaard, Lisbeth Kalum
  • Polypeptides having peroxygenase activity
    Patent number: 9587260
    Abstract: The present invention relates to isolated polypeptides having peroxygenase activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: March 7, 2017
    Assignee: Novozymes A/S
    Inventors: Sara Landvik, Lars Henrik Oestergaard, Lisbeth Kalum
  • Polypeptides Having Peroxygenase Activity and Polynucleotides Encoding Same
    Publication number: 20170029787
    Abstract: The present invention relates to isolated polypeptides having peroxygenase activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: October 11, 2016
    Publication date: February 2, 2017
    Applicant: Novozymes A/S
    Inventors: Sara Landvik, Lars Henrik Oestergaard, Lisbeth Kalum
  • Factor VIII Molecules with Reduced VWF Binding
    Publication number: 20170020992
    Abstract: The present invention relates to a recombinant Factor VIII molecule, wherein said molecule has reduced vWF binding capacity, and wherein said molecule is covalently conjugated with at least one side group.
    Type: Application
    Filed: October 7, 2016
    Publication date: January 26, 2017
    Inventors: Gert Bolt, Bernd Peschke, Mikael Kofod-Hansen, Jens Buchardt, Henning Ralf Stennicke, Henrik Oestergaard, Marianne Kjalke, Eva H. Norling Olsen, Jens Jacob Hansen, Magali Zundel
  • Polypeptides having peroxygenase activity
    Patent number: 9534208
    Abstract: The present invention relates to isolated polypeptides having peroxygenase activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. A polynucleotide encoding a peroxygenase was isolated from Daldinia caldariorum.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: January 3, 2017
    Assignee: Novozymes A/S
    Inventors: Sara Landvik, Lars Henrik Oestergaard, Lisbeth Kalum
  • Peroxygenase Variants
    Publication number: 20160376566
    Abstract: The present invention relates to peroxygenase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: December 1, 2014
    Publication date: December 29, 2016
    Applicant: Novozymes A/S
    Inventors: Jesper VIND, Lars Henrik OESTERGAARD, Leonardo DE MARIA, Lisbeth KALUM, Eleni AMOURGI
  • Polypeptides Having Peroxygenase Activity
    Publication number: 20160369309
    Abstract: The present invention relates to isolated polypeptides having peroxygenase activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: August 22, 2016
    Publication date: December 22, 2016
    Applicant: Novozymes A/S
    Inventors: Sara Landvik, Lars Henrik Oestergaard, Lisbeth Kalum